ASTRAZENECA PLC (ZEG.DE) Fundamental Analysis & Valuation

FRA:ZEG • GB0009895292

Current stock price

160.7 EUR
+0.95 (+0.59%)
Last:

This ZEG.DE fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

7

1. ZEG.DE Profitability Analysis

1.1 Basic Checks

  • ZEG had positive earnings in the past year.
  • ZEG had a positive operating cash flow in the past year.
  • Each year in the past 5 years ZEG has been profitable.
  • In the past 5 years ZEG always reported a positive cash flow from operatings.
ZEG.DE Yearly Net Income VS EBIT VS OCF VS FCFZEG.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5B 10B

1.2 Ratios

  • The Return On Assets of ZEG (8.96%) is better than 63.64% of its industry peers.
  • Looking at the Return On Equity, with a value of 21.01%, ZEG is in the better half of the industry, outperforming 65.45% of the companies in the same industry.
  • ZEG has a Return On Invested Capital of 13.63%. This is in the better half of the industry: ZEG outperforms 65.45% of its industry peers.
  • ZEG had an Average Return On Invested Capital over the past 3 years of 12.48%. This is below the industry average of 14.78%.
  • The 3 year average ROIC (12.48%) for ZEG is below the current ROIC(13.63%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 8.96%
ROE 21.01%
ROIC 13.63%
ROA(3y)7.2%
ROA(5y)5.03%
ROE(3y)17.82%
ROE(5y)12.53%
ROIC(3y)12.48%
ROIC(5y)10.5%
ZEG.DE Yearly ROA, ROE, ROICZEG.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15 20

1.3 Margins

  • ZEG has a better Profit Margin (17.41%) than 69.09% of its industry peers.
  • In the last couple of years the Profit Margin of ZEG has grown nicely.
  • Looking at the Operating Margin, with a value of 23.86%, ZEG is in line with its industry, outperforming 58.18% of the companies in the same industry.
  • In the last couple of years the Operating Margin of ZEG has grown nicely.
  • ZEG's Gross Margin of 81.31% is amongst the best of the industry. ZEG outperforms 85.45% of its industry peers.
  • ZEG's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 23.86%
PM (TTM) 17.41%
GM 81.31%
OM growth 3Y6.24%
OM growth 5Y7.63%
PM growth 3Y32.91%
PM growth 5Y7.71%
GM growth 3Y0.34%
GM growth 5Y0.28%
ZEG.DE Yearly Profit, Operating, Gross MarginsZEG.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20 40 60 80

4

2. ZEG.DE Health Analysis

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so ZEG is still creating some value.
  • ZEG has about the same amout of shares outstanding than it did 1 year ago.
  • Compared to 5 years ago, ZEG has more shares outstanding
  • The debt/assets ratio for ZEG has been reduced compared to a year ago.
ZEG.DE Yearly Shares OutstandingZEG.DE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B
ZEG.DE Yearly Total Debt VS Total AssetsZEG.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20B 40B 60B 80B 100B

2.2 Solvency

  • An Altman-Z score of 3.77 indicates that ZEG is not in any danger for bankruptcy at the moment.
  • ZEG's Altman-Z score of 3.77 is in line compared to the rest of the industry. ZEG outperforms 54.55% of its industry peers.
  • The Debt to FCF ratio of ZEG is 3.42, which is a good value as it means it would take ZEG, 3.42 years of fcf income to pay off all of its debts.
  • The Debt to FCF ratio of ZEG (3.42) is better than 63.64% of its industry peers.
  • A Debt/Equity ratio of 0.55 indicates that ZEG is somewhat dependend on debt financing.
  • ZEG has a Debt to Equity ratio of 0.55. This is in the better half of the industry: ZEG outperforms 61.82% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.55
Debt/FCF 3.42
Altman-Z 3.77
ROIC/WACC1.49
WACC9.14%
ZEG.DE Yearly LT Debt VS Equity VS FCFZEG.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10B 20B 30B 40B

2.3 Liquidity

  • ZEG has a Current Ratio of 0.94. This is a bad value and indicates that ZEG is not financially healthy enough and could expect problems in meeting its short term obligations.
  • ZEG has a worse Current ratio (0.94) than 81.82% of its industry peers.
  • A Quick Ratio of 0.72 indicates that ZEG may have some problems paying its short term obligations.
  • With a Quick ratio value of 0.72, ZEG is not doing good in the industry: 74.55% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 0.94
Quick Ratio 0.72
ZEG.DE Yearly Current Assets VS Current LiabilitesZEG.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10B 20B 30B

5

3. ZEG.DE Growth Analysis

3.1 Past

  • The earnings per share for ZEG have decreased by -1.34% in the last year.
  • ZEG shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 15.04% yearly.
  • The Revenue has grown by 8.63% in the past year. This is quite good.
  • ZEG shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 17.15% yearly.
EPS 1Y (TTM)-1.34%
EPS 3Y6.74%
EPS 5Y15.04%
EPS Q2Q%-49.28%
Revenue 1Y (TTM)8.63%
Revenue growth 3Y9.82%
Revenue growth 5Y17.15%
Sales Q2Q%4.11%

3.2 Future

  • The Earnings Per Share is expected to grow by 15.20% on average over the next years. This is quite good.
  • The Revenue is expected to grow by 6.82% on average over the next years.
EPS Next Y30.41%
EPS Next 2Y20.69%
EPS Next 3Y17.63%
EPS Next 5Y15.2%
Revenue Next Year6.06%
Revenue Next 2Y5.93%
Revenue Next 3Y6.22%
Revenue Next 5Y6.82%

3.3 Evolution

  • The EPS growth rate is stable: in the next years the growth will be about the same than in the last years.
  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
ZEG.DE Yearly Revenue VS EstimatesZEG.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 20B 40B 60B 80B
ZEG.DE Yearly EPS VS EstimatesZEG.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 5 10 15

4

4. ZEG.DE Valuation Analysis

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 23.53, the valuation of ZEG can be described as rather expensive.
  • The rest of the industry has a similar Price/Earnings ratio as ZEG.
  • ZEG is valuated at similar levels of the S&P average when we compare the Price/Earnings ratio to 25.70, which is the current average of the S&P500 Index.
  • With a Price/Forward Earnings ratio of 18.05, ZEG is valued on the expensive side.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of ZEG is on the same level as its industry peers.
  • ZEG's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 23.84.
Industry RankSector Rank
PE 23.53
Fwd PE 18.05
ZEG.DE Price Earnings VS Forward Price EarningsZEG.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • ZEG's Enterprise Value to EBITDA ratio is in line with the industry average.
  • ZEG's Price/Free Cash Flow ratio is in line with the industry average.
Industry RankSector Rank
P/FCF 34.09
EV/EBITDA 16.14
ZEG.DE Per share dataZEG.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30

4.3 Compensation for Growth

  • The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • The decent profitability rating of ZEG may justify a higher PE ratio.
  • ZEG's earnings are expected to grow with 17.63% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.77
PEG (5Y)1.56
EPS Next 2Y20.69%
EPS Next 3Y17.63%

4

5. ZEG.DE Dividend Analysis

5.1 Amount

  • ZEG has a Yearly Dividend Yield of 1.64%. Purely for dividend investing, there may be better candidates out there.
  • ZEG's Dividend Yield is comparable with the industry average which is at 1.94.
  • ZEG's Dividend Yield is comparable with the S&P500 average which is at 1.89.
Industry RankSector Rank
Dividend Yield 1.64%

5.2 History

  • The dividend of ZEG has a limited annual growth rate of 3.33%.
Dividend Growth(5Y)3.33%
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

  • 48.62% of the earnings are spent on dividend by ZEG. This is a bit on the high side, but may be sustainable.
  • ZEG's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP48.62%
EPS Next 2Y20.69%
EPS Next 3Y17.63%
ZEG.DE Yearly Income VS Free CF VS DividendZEG.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B 8B 10B
ZEG.DE Dividend Payout.ZEG.DE Dividend Payout, showing the Payout Ratio.ZEG.DE Dividend Payout.PayoutRetained Earnings

ZEG.DE Fundamentals: All Metrics, Ratios and Statistics

ASTRAZENECA PLC

FRA:ZEG (2/5/2026, 7:00:00 PM)

160.7

+0.95 (+0.59%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)02-10
Earnings (Next)04-29
Inst Owners49.17%
Inst Owner ChangeN/A
Ins Owners0.02%
Ins Owner ChangeN/A
Market Cap249.13B
Revenue(TTM)58.74B
Net Income(TTM)10.22B
Analysts82.94
Price Target175.52 (9.22%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.64%
Yearly Dividend2.7
Dividend Growth(5Y)3.33%
DP48.62%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-25.37%
Min EPS beat(2)-60.38%
Max EPS beat(2)9.64%
EPS beat(4)2
Avg EPS beat(4)-12.23%
Min EPS beat(4)-60.38%
Max EPS beat(4)9.64%
EPS beat(8)4
Avg EPS beat(8)-5.74%
EPS beat(12)7
Avg EPS beat(12)-2.63%
EPS beat(16)11
Avg EPS beat(16)-0.36%
Revenue beat(2)1
Avg Revenue beat(2)-1.31%
Min Revenue beat(2)-4.83%
Max Revenue beat(2)2.2%
Revenue beat(4)1
Avg Revenue beat(4)-2.92%
Min Revenue beat(4)-5.08%
Max Revenue beat(4)2.2%
Revenue beat(8)4
Avg Revenue beat(8)-0.54%
Revenue beat(12)5
Avg Revenue beat(12)-0.86%
Revenue beat(16)6
Avg Revenue beat(16)-0.78%
PT rev (1m)5.49%
PT rev (3m)12.4%
EPS NQ rev (1m)-1.75%
EPS NQ rev (3m)-1.48%
EPS NY rev (1m)1.58%
EPS NY rev (3m)-0.37%
Revenue NQ rev (1m)-0.41%
Revenue NQ rev (3m)-0.71%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.59%
Valuation
Industry RankSector Rank
PE 23.53
Fwd PE 18.05
P/S 5.03
P/FCF 34.09
P/OCF 20.28
P/B 6.07
P/tB N/A
EV/EBITDA 16.14
EPS(TTM)6.83
EY4.25%
EPS(NY)8.9
Fwd EY5.54%
FCF(TTM)4.71
FCFY2.93%
OCF(TTM)7.93
OCFY4.93%
SpS31.94
BVpS26.46
TBVpS-5.67
PEG (NY)0.77
PEG (5Y)1.56
Graham Number63.77
Profitability
Industry RankSector Rank
ROA 8.96%
ROE 21.01%
ROCE 16.8%
ROIC 13.63%
ROICexc 14.63%
ROICexgc 59.47%
OM 23.86%
PM (TTM) 17.41%
GM 81.31%
FCFM 14.76%
ROA(3y)7.2%
ROA(5y)5.03%
ROE(3y)17.82%
ROE(5y)12.53%
ROIC(3y)12.48%
ROIC(5y)10.5%
ROICexc(3y)13.49%
ROICexc(5y)11.39%
ROICexgc(3y)81.92%
ROICexgc(5y)83.55%
ROCE(3y)15.36%
ROCE(5y)12.92%
ROICexgc growth 3Y-25.55%
ROICexgc growth 5Y0.81%
ROICexc growth 3Y9.13%
ROICexc growth 5Y9.72%
OM growth 3Y6.24%
OM growth 5Y7.63%
PM growth 3Y32.91%
PM growth 5Y7.71%
GM growth 3Y0.34%
GM growth 5Y0.28%
F-Score7
Asset Turnover0.51
Health
Industry RankSector Rank
Debt/Equity 0.55
Debt/FCF 3.42
Debt/EBITDA 1.36
Cap/Depr 103%
Cap/Sales 10.05%
Interest Coverage 10.65
Cash Conversion 73.79%
Profit Quality 84.79%
Current Ratio 0.94
Quick Ratio 0.72
Altman-Z 3.77
F-Score7
WACC9.14%
ROIC/WACC1.49
Cap/Depr(3y)80.57%
Cap/Depr(5y)64.46%
Cap/Sales(3y)8.93%
Cap/Sales(5y)7.69%
Profit Quality(3y)99.49%
Profit Quality(5y)775.68%
High Growth Momentum
Growth
EPS 1Y (TTM)-1.34%
EPS 3Y6.74%
EPS 5Y15.04%
EPS Q2Q%-49.28%
EPS Next Y30.41%
EPS Next 2Y20.69%
EPS Next 3Y17.63%
EPS Next 5Y15.2%
Revenue 1Y (TTM)8.63%
Revenue growth 3Y9.82%
Revenue growth 5Y17.15%
Sales Q2Q%4.11%
Revenue Next Year6.06%
Revenue Next 2Y5.93%
Revenue Next 3Y6.22%
Revenue Next 5Y6.82%
EBIT growth 1Y10.05%
EBIT growth 3Y16.67%
EBIT growth 5Y26.09%
EBIT Next Year23.4%
EBIT Next 3Y12.45%
EBIT Next 5Y11.39%
FCF growth 1Y19.18%
FCF growth 3Y6.21%
FCF growth 5Y31.64%
OCF growth 1Y22.88%
OCF growth 3Y14.12%
OCF growth 5Y24.88%

ASTRAZENECA PLC / ZEG.DE Fundamental Analysis FAQ

What is the fundamental rating for ZEG stock?

ChartMill assigns a fundamental rating of 5 / 10 to ZEG.DE.


What is the valuation status of ASTRAZENECA PLC (ZEG.DE) stock?

ChartMill assigns a valuation rating of 3 / 10 to ASTRAZENECA PLC (ZEG.DE). This can be considered as Overvalued.


What is the profitability of ZEG stock?

ASTRAZENECA PLC (ZEG.DE) has a profitability rating of 7 / 10.


What is the valuation of ASTRAZENECA PLC based on its PE and PB ratios?

The Price/Earnings (PE) ratio for ASTRAZENECA PLC (ZEG.DE) is 23.53 and the Price/Book (PB) ratio is 6.07.


Can you provide the expected EPS growth for ZEG stock?

The Earnings per Share (EPS) of ASTRAZENECA PLC (ZEG.DE) is expected to grow by 30.41% in the next year.